Healthcare - Biotechnology - NASDAQ - US
$ 5.8
-3.65 %
$ 328 M
Market Cap
-6.82
P/E
BALANCE SHEET
290 M
ASSETS
12 M
LIABILITIES
278 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Design Therapeutics, Inc.
| Current Assets | 285 M |
| Cash & Short-Term Investments | 282 M |
| Receivables | 1.43 M |
| Other Current Assets | 1.35 M |
| Non-Current Assets | 5.06 M |
| Long-Term Investments | 0 |
| PP&E | 4.63 M |
| Other Non-Current Assets | 430 K |
| Current Liabilities | 9.62 M |
| Accounts Payable | 1.94 M |
| Short-Term Debt | 716 K |
| Other Current Liabilities | 6.97 M |
| Non-Current Liabilities | 2.33 M |
| Long-Term Debt | 4.67 M |
| Other Non-Current Liabilities | -2.33 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 21.2 | 26.5 | 298.6 | 2.4 | 77 K |
| Short Term Investments | 260.6 | 303.9 | 85.5 | 33.7 | 0 |
| Receivables | 1.4 | 1.1 | 0.1 | 10 K | 0 |
| Inventory | 0 | (1.1) | 1.3 | 0.1 | 0 |
| Other Current Assets | 1.4 | 8.3 | 1.3 | 0.1 | 5 K |
| Total Current Assets | 284.6 | 335.1 | 385.4 | 36.2 | 90 K |
| PP&E | 4.6 | 5.6 | 5.1 | 71 K | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 0.4 | 0.5 | 0 | 0.2 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 289.6 | 341.1 | 390.6 | 36.5 | 90 K |
| LIABILITIES | |||||
| Accounts Payable | 1.9 | 3.0 | 1.6 | 1.4 | 2.5 |
| Short Term Debt | 0.7 | 0.6 | 0.5 | 0 | 0.7 |
| Other Current Liabilities | 7.0 | 7.1 | 3.2 | 0.9 | 0.4 |
| Total Current Liabilities | 9.6 | 10.8 | 5.3 | 2.3 | 3.7 |
| Long Term Debt | 4.7 | 6.1 | 6.3 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | (2.3) | (3.1) | (3.1) | 45.5 | 1 K |
| Total Liabilities | 12.0 | 13.8 | 8.4 | 47.8 | 3.7 |
| EQUITY | |||||
| Common Stock | 6 K | 6 K | 6 K | 1 K | 1 K |
| Retained Earnings | (177.6) | (110.8) | (47.5) | (11.9) | (3.6) |
| Other Accumulative Comprehensive Income/Loss | 62 K | (3.4) | (0.2) | 0.2 | 0 |
| Total Equity | 277.7 | 327.3 | 382.1 | (11.3) | (3.6) |
| Total Liabilities and Equity | 289.6 | 341.1 | 390.6 | 36.5 | 90 K |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 56.0 | 55.7 | 45.9 | 27.2 | 27.2 |